Tarsus Pharmaceuticals TARS
NASDAQ TARS
$76.75 -0.06 (-0.08%)
As of: Sep 29, 2026 · 3:59 PM EDT

Tarsus Pharmaceuticals (TARS) Share-based Compensation (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) posted Share-based Compensation of $13.29 million for Q2 2026, up 61.4% from $8.23 million a year earlier and up 11.0% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Share-based Compensation (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Tarsus Pharmaceuticals was $51.81 million, up 72.8% year-over-year; for FY2025, it came in at $41.72 million, up 50.0% from FY2024.

  • Annual Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 68.0% (FY2020 to FY2025).
  • In prior years, Tarsus Pharmaceuticals' Share-based Compensation was $27.82 million in FY2024 (+40.3%), $19.83 million in FY2023 (+47.3%), $13.46 million in FY2022 (+59.2%) and $8.46 million in FY2021 (+171.4%).
  • Quarterly Share-based Compensation has run from a low of $782,000 in Q3 2021 to a high of $14.31 million in Q4 2025 over five years.
  • On a year-over-year basis, Share-based Compensation has increased in each of the last 16 quarters, with growth averaging 50.6% over the last eight quarters.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2022, with growth of 358.2%; the weakest was Q3 2021, with a decline of 73.4%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $11.97 million (Q1 2026), $14.31 million (Q4 2025) and $12.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Tarsus Pharmaceuticals 3.32 Bn 2.27 Bn 161.80 Mn 13.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.29 Mn
Mar 31, 2026 11.97 Mn
Dec 31, 2025 14.31 Mn
Sep 30, 2025 12.24 Mn
Jun 30, 2025 8.23 Mn
Mar 31, 2025 6.93 Mn
Dec 31, 2024 7.40 Mn
Sep 30, 2024 7.42 Mn
Jun 30, 2024 7.48 Mn
Mar 31, 2024 5.52 Mn
Dec 31, 2023 5.48 Mn
Sep 30, 2023 5.25 Mn
Jun 30, 2023 5.19 Mn
Mar 31, 2023 3.91 Mn
Dec 31, 2022 3.67 Mn
Sep 30, 2022 3.58 Mn
Jun 30, 2022 3.53 Mn
Mar 31, 2022 2.67 Mn
Dec 31, 2021 2.18 Mn
Sep 30, 2021 782,000.00
API Access

Tarsus Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TARS&period=max&api_key=YOUR_API_KEY